106 results about "Infra-orbital nerve" patented technology

Apparatus for treatment is provided, including one or more electrodes, configured to be applied to a site of a subject, and adverse cerebrovascular condition treatment functionality. The functionality comprises a control unit configured to drive the one or more electrodes to apply electrical stimulation to the site during a plurality of stimulation periods which includes at least first and last stimulation periods, set an inter-period interval between initiation of the first stimulation period and initiation of the last stimulation period to be at least 24 hours, and configure the stimulation during the first and last stimulation periods to induce at least one neuroprotective occurrence selected from the group consisting of: an increase in cerebral blood flow (CBF) of the subject, and a release of one or more neuroprotective substances. The site is selected from the group consisting of: a sphenopalatine ganglion (SPG), a greater palatine nerve, a lesser palatine nerve, a sphenopalatine nerve, a communicating branch between a maxillary nerve and an SPG, an otic ganglion, an afferent fiber going into the otic ganglion, an efferent fiber going out of the otic ganglion, an infraorbital nerve, a vidian nerve, a greater superficial petrosal nerve, and a lesser deep petrosal nerve. Additional embodiments are also described.

Devices and methods are disclosed that allow a patient to self-treat a medical condition, such as migraine headache and trigeminal neuralgia and the like, by noninvasive electrical stimulation of nerves of the head, particularly supraorbital, supratrochlear, infraorbital, and mental nerves in the vicinity of their foramen or notch. The system comprises a handheld mobile device, such as a smartphone, that is applied to the surface of the patient's head. One or more electrodes on the mobile device apply electrical impulses transcutaneously through the patient's skin to the targeted nerve to treat the medical condition. The system is designed to address problems that arise particularly during self-treatment, when a medical professional is not present.

A guide for administering an injection including a guide body contoured for a human mandible; and at least one needle indexing guide on the guide body for the insertion of a needle there through, the guide use to provide a predictable and repeatable way of administering an injection to block a nerve.

Bifurcated leads may simplify implantation procedures associated with electrical single therapy at two distinct anatomical locations, such as a left and a right occipital nerve.

A composition and method of treatment of neuromuscular, neuromuscular degenerative, neurodegenerative, autoimmune, developmental, traumatic, hearing loss related, and/or metabolic diseases, including spinal muscular atrophy (SMA) syndrome (SMA1, SMA2, SMA3, and SMA4, also called Type I, II, III and IV), traumatic brain injury (TBI), concussion, keratoconjunctivitis sicca (Dry Eye Disease), glaucoma, Sjogren's syndrome, rheumatoid arthritis, post-LASIK surgery, anti-depressants use, Wolfram Syndrome, and Wolcott-Rallison syndrome. The composition is selected from the group consisting of 2,3-DNP, 2,4-DNP, 2,5-DNP, 2,6-DNP, 3,4-DNP, or 3,5-DNP, bipartite 2,3-dinitrophenol, 2,4-dinitrophenol, 2,5-dinitrophenol, 2,6-dinitrophenol, 3,4-dinitrophenol, or 3,5-dinitrophenol (2,3-DNP, 2,4-DNP, 2,5-DNP, 2,6-DNP, 3,4-DNP, or 3,5-DNP) prodrugs; Gemini prodrugs, bioprecursor molecules, and combinations thereof. A dose of the composition for treatment of neurodegenerative diseases may be from about 0.01 mg/kg of body weight to about 50 mg/kg of body weight of the patient in need of treatment. A dose of the composition for treatment of metabolic diseases may be from about 1 mg/70 kg of body weight to about 100 mg/70 kg of body weight of the patient in need of treatment, and a maximum dose per day is about 200 mg/70 kg of body weight of the patient in need of treatment.

The invention discloses a multi-angle locking and fixing humerus straight type interlocking intramedullary pin. The multi-angle locking and fixing humerus straight type interlocking intramedullary pincomprises a humerus intramedullary pin main pin, wherein the humerus intramedullary pin main pin adopts a hollow structure, and comprises a near end intramedullary pin, a far end intramedullary pin and a connecting section; the diameter of the near end intramedullary pin is greater than that of the far end intramedullary pin; one end of the near end intramedullary pin is in transition connectionwith the far end intramedullary pin through the connecting section, and the inner part of the other end of the near end intramedullary pin is connected with a terminal cap; the near end intramedullarypin, the far end intramedullary pin and the connecting section adopt an integrated structure; the diameter of the near end intramedullary pin is 9mm, a plurality of pin holes are formed in the near end intramedullary pin and the far end intramedullary pin; bone screws are arranged in the pin holes; and the bone screws in the near end intramedullary pin are multi-angle screws. According to the multi-angle locking and fixing humerus straight type interlocking intramedullary pin disclosed by the invention, the opportunity of selecting appropriate humerus intramedullary pin main pin according tohumerus individual dissection differences is increased, and the operation risk of generating fracture of humeral head and injury of axillary nerve caused by that an opening in the humerus head part islarge is reduced.

An orifice probe, particularly for detecting if a patient has or has a risk of having cauda equina syndrome and a method for using same, the probe having a body for insertion into the anus of a patient, a sensing device for measuring at least one of the rectal tone and perianal or rectal sensation, and an output device for yielding at least one of the measurement of the rectal tone of the patient and whether the patient has perianal or rectal sensation.

The invention provides a sacral nerve puncture guide plate and a construction method thereof. The guide plate comprises a base plate, an outer guide pipe and an inner guide pipe, wherein the outer guide pipe is arranged on the outer side face of the base plate; the inner guide pipe is coaxially arranged in the outer guide pipe; the inner guide pipe penetrates through the base plate; and the end face of the end, penetrating through the base plate, of the inner guide pipe is flush with the inner side face of the base plate. According to the sacral nerve puncture guide plate provided by the invention, the end face of the end, penetrating through the base plate, of the inner guide pipe is flush with the inner side face of the base plate, so that the tail end face of the inner guide pipe directly abuts against the skin in use and can be attached to the surface of the skin, whole-course guided puncture is achieved, and puncture errors are avoided.

An expandable intervertebral spacer has a plurality of arms. The arms can be retracted or extended. The spacer has a width that is narrower than the width between the nerve roots near the posterior approach to an intervertebral space. Once inserted into the intervertebral space, the arms can be deployed. The deployed arms expand the height and width of the spacer. Once deployed, the spacer stabilizes two adjacent vertebrae. The arms are interconnected mechanically to deploy simultaneously.

Methods and systems for improving nerve stimulation are disclosed which relate to shaping characteristics of the stimulation field such as by using different geometries and locations of stimulation. In embodiments, systems and methods are provided to improve selective modulation of specific targeted neural substrate, while minimizing the activation of adjacent non-targeted nervous tissue. While aspects of the disclosed technologies can be applied to any part of the central and peripheral nervous systems for treatment various disorders and providing symptom relief to provide for therapy related to pelvic floor disorders such as overactive bladder

The invention provides a sacrum nerve puncture path simulation planning system and device, and relates to puncture operation simulation. The sacrum nerve puncture path simulation planning system comprises an image obtaining module and a path simulation planning module, and the image obtaining module is configured to obtain scanning images of sacrum, sacral foramen and a positioning grid located at a lumbosacral part; and the path simulation planning module is configured to establish a three-dimensional model of the sacrum, the sacral foramen and the positioning grid according to the scanned image, and acquire a virtual puncture path penetrating through the positioning grid to reach a sacrum set position and an intersection point of the positioning grid and the virtual puncture path according to the three-dimensional model. The problems that at present, sacral nerve holes are directly punctured for many times, and pain of patients is large are solved. By acquiring the scanning images of the positioning grid, sacrum and sacral foramen, taking the positioning grid as a positioning reference, reconstructing the three-dimensional model of the sacrum, the sacral foramen and the positioning grid, taking a reference of penetrating through the positioning grid to reach a sacrum set position, and establishing a plurality of virtual puncture paths, a human organ state and an actual puncture process are simulated.

The invention relates to the technical field of nerve vertigo and discloses a cranial nerve injury patient vertigo protection mechanism. The mechanism comprises a shell, wherein an air bag is fixedly connected to the inner side of the shell, a connecting block is fixedly connected to the inner wall of the shell, an electrode column is fixedly connected to the inner wall of the connecting block, and a leather ring is fixedly connected to the outer side of the electrode column; an electric heating wire is fixedly connected to the inner side of the leather ring, a round hole is formed in an inner wall of the connecting block, an electromagnet is fixedly connected to the inner wall of the shell, and a limiting block is elastically connected to the position, close to the outer side of the electromagnet, of the inner wall of the shell. According to the vertigo protection mechanism for the cranial nerve injury patient, through explosion of sodium azide in the leather ring, when the cranial nerve patient is in a standing state, if vertigo occurs, the cranial nerve patient topples over, a head of the cranial nerve patient is prevented from colliding with the ground, damage to the head is avoided, and damage to the cranial nerve patient is relieved; and potential safety hazards in rehabilitation of cranial nerve patients are eliminated.

Provided is a catheter including a shaft having a distal end and a loop disposed near the distal end and configured to curl around a tissue and receive, via the shaft, energy to denervate at least a portion of the tissue. The loop includes: a first film capable of bending to curl around the tissue; a plurality of electrodes disposed on the first film and arranged in parallel to each other with a predetermined distance; a sensor disposed at a position corresponding to a position between the plurality of electrodes.

Methods, systems and devices are provided to stimulate the vestibular system in such a way as to influence the neurological components of the autonomic nervous system and reduce an anxiety level in a subject. A device with one or more electrodes placed over a subject's scalp provides vestibular nerve stimulation (VeNS) to the vestibular nerve, which is then carried into the vestibular nucleus in the brainstem and thereafter transmitted to the neurological components of the autonomic nervous system to reduce a physiological reaction to an anxiety event. The characteristics of the stimulation signal and duration of the treatment are configured to allow the treatment to be delivered before, during or after an anxiety event to potentially prevent or at the very least reduce an anxiety response in the subject.

Neuromodulation of cranial nerves can be used to treat sleep or breathing disorders, among other diseases and disorders. A neuromodulation system can include a housing configured for implantation in an anterior cervical region of a patient, such as at or under a mandible of the patient, such as at least partially in one or more of a submental triangle, a submandibular triangle, and a carotid triangle. The system can include an electrode lead coupled to the housing, and the electrode lead can include an electrode configured to be disposed at or near a cranial nerve target in the patient. The system can be configured to generate electrical neuromodulation signals for delivery to the cranial nerve target using the electrode.